Notably, our results provide a novel perspective on the role of the SORBS1 protein in attenuating the efficacy of cisplatin chemotherapy by increasing the accumulation of p53 protein during the treatment of breast and lung cancers. This evidence concerns the gene TP53 and lung carcinoma.